- Get link
- Other Apps
GPT Healthcare, a provider of multi-specialty healthcare services operating in two states, marked a significant milestone as its Initial Public Offering (IPO) worth Rs 525.14 crore was listed on the market.
The IPO subscription window was open from February 22 to 26, generating substantial interest from investors and witnessing an overall subscription of 8.52 times.
The IPO comprised new shares worth Rs 40 crore and an Offer for Sale (OFS) of 2,60,82,786 existing shares with a face value of Rs 10. The IPO price was set at Rs 186 per share.
The listing day saw an impressive debut for GPT Healthcare’s shares, opening at Rs 216.15 on the BSE and Rs 215.00 on the NSE, translating to a listing gain of over 16 percent for early investors.
However, the stock witnessed a slight decline post-listing, settling at Rs 205.50 on the BSE. Despite the dip, IPO investors still realized a profit of 10.48 percent.
The strong response to the IPO was evident in the subscription figures, with Qualified Institutional Buyers (QIB) oversubscribing 17.30 times, Non-Institutional Investors (NII) 11.02 times, and retail investors 2.44 times.
The funds raised through the OFS will directly benefit the existing shareholders selling their stakes, while the capital generated from the new shares will be allocated towards loan repayment and general corporate purposes.
GPT Healthcare, operating under the ILS Hospitals brand, maintains a robust financial profile.
The company’s net profit exhibited a consistent upward trajectory, reaching Rs 41.66 crore in the financial year 2022 and Rs 39.01 crore in 2023, compared to Rs 21.09 crore in 2021.
Over the same period, the company’s revenue demonstrated a compound annual growth rate (CAGR) of over 21 percent, culminating in a figure of Rs 366.73 crore in the financial year 2023.
As of the current financial year 2023-24, the company has sustained its positive momentum, reporting a net profit of Rs 23.49 crore and a revenue of Rs 206.70 crore for the first half (April-September 2024).
The successful IPO listing positions GPT Healthcare for further expansion and development within the dynamic healthcare industry.
Source:
GPT Healthcare IPO Listing: Stock Lists at 16% premium to IPO price
Comments
Post a Comment